# Isolated Glenohumeral Corticosteroid Injection Versus Concomitant Capsule Preserving Hydrodilatation

> **NCT06493656** · NA · COMPLETED · sponsor: **Chuncheon Sacred Heart Hospital** · enrollment: 50 (actual)

## Conditions studied

- Adhesive Capsulitis
- Adhesive Capsulitis of Shoulder

## Interventions

- **PROCEDURE:** Ultrasound-guided glenohumeral space isolated corticosteroid injection
- **PROCEDURE:** Ultrasound-guided glenohumeral space concomitant hydrodilatation with corticosteroid injection
- **DRUG:** 1mL of Triamcinolone (40mg/1mL) Injectable Solution
- **DRUG:** 4mL of Lidocaine 1% Solution Injectable Solution
- **DRUG:** 15mL of Normal Saline

## Key facts

- **NCT ID:** NCT06493656
- **Lead sponsor:** Chuncheon Sacred Heart Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12-05
- **Primary completion:** 2015-11-17
- **Final completion:** 2015-11-17
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2024-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06493656

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06493656, "Isolated Glenohumeral Corticosteroid Injection Versus Concomitant Capsule Preserving Hydrodilatation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06493656. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*